Additional file 1: Table S1. of Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population

cardiovascular disease event incidence (per 1000 person-year) of different serum lipid markers and lipid indices among men, women and total participants (n=5054); Tehran Lipid and Glucose Study (TLGS) (2001-2012). Table S2 cardiovascular mortality rate (per 1000 person-year) of different serum lipid markers and lipid indices among total participants (n=5518); Tehran Lipid and Glucose Study (TLGS) (2001-2012). Table S3 Non-cardiovascular mortality rate (per 1000 person-year) of different serum lipid markers and lipid indices among total participants (n=5518); Tehran Lipid and Glucose Study (TLGS) (2001-2012). Table S4 Hazard ratios of lipid measures for predicting first cardiovascular disease events among participants without prevalent CVD in those with available data on HOMA-IR (n=1548); Tehran Lipid and Glucose Study (TLGS) (2001-2012)*. Table S5 Hazard ratios of lipid measures for predicting first cardiovascular disease events among participants without prevalent CVD based on lipid profile tertiles CVD in those with available data on HOMA-IR (n=1548); Tehran Lipid and Glucose Study (TLGS) (2001-2012). (DOCX 65 kb)